Ken Ishitani

825 total citations
30 papers, 498 citations indexed

About

Ken Ishitani is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Ken Ishitani has authored 30 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Obstetrics and Gynecology, 8 papers in Reproductive Medicine and 7 papers in Molecular Biology. Recurrent topics in Ken Ishitani's work include Ovarian cancer diagnosis and treatment (6 papers), Bone health and osteoporosis research (6 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Ken Ishitani is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Bone health and osteoporosis research (6 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Ken Ishitani collaborates with scholars based in Japan, United States and Vietnam. Ken Ishitani's co-authors include Hiroaki Ohta, Shiro Nozawa, Hideo Matsui, Teruo Okano, Tatsuya Shimizu, Kazuya Makita, Shigeaki Kato, Hirochika Kitagawa, Hiroya Okano and Jennifer Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Ken Ishitani

30 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Ishitani Japan 15 107 89 86 79 67 30 498
Julien Collette Belgium 16 162 1.5× 149 1.7× 158 1.8× 97 1.2× 31 0.5× 32 673
Arin K. Oestreich United States 11 135 1.3× 77 0.9× 59 0.7× 44 0.6× 34 0.5× 17 465
N. H. Cho South Korea 7 271 2.5× 58 0.7× 46 0.5× 297 3.8× 18 0.3× 10 647
C M Francucci Italy 13 132 1.2× 161 1.8× 80 0.9× 106 1.3× 9 0.1× 20 474
B.J. Riis Denmark 17 196 1.8× 138 1.6× 79 0.9× 112 1.4× 7 0.1× 40 1.9k
Hasan Esen Türkiye 13 103 1.0× 20 0.2× 106 1.2× 32 0.4× 107 1.6× 51 530
Chan Yoon South Korea 12 85 0.8× 33 0.4× 198 2.3× 151 1.9× 19 0.3× 26 492
Robert Klepacz Poland 12 92 0.9× 14 0.2× 109 1.3× 67 0.8× 23 0.3× 39 469
Sushant Kumar Das China 14 34 0.3× 17 0.2× 64 0.7× 29 0.4× 41 0.6× 31 515
Antonia Sioga Greece 10 82 0.8× 11 0.1× 49 0.6× 52 0.7× 25 0.4× 54 383

Countries citing papers authored by Ken Ishitani

Since Specialization
Citations

This map shows the geographic impact of Ken Ishitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Ishitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Ishitani more than expected).

Fields of papers citing papers by Ken Ishitani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Ishitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Ishitani. The network helps show where Ken Ishitani may publish in the future.

Co-authorship network of co-authors of Ken Ishitani

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Ishitani. A scholar is included among the top collaborators of Ken Ishitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Ishitani. Ken Ishitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Osuga, Yutaka, et al.. (2023). Short‐term efficacy and safety of early medical abortion in Japan: A multicenter prospective study. Reproductive Medicine and Biology. 22(1). e12512–e12512. 3 indexed citations
2.
Ishitani, Ken, Tetsuya Ito, Hitoshi Sugiyama, et al.. (2021). Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study. International Journal of Clinical Oncology. 26(6). 1130–1138. 6 indexed citations
3.
Ishitani, Ken, Yoshiaki Norimatsu, Kenji Yanoh, et al.. (2019). Evaluation of cellular adequacy in endometrial liquid‐based cytology. Cytopathology. 30(5). 526–531. 2 indexed citations
4.
Abe, Yuki, et al.. (2018). Possible Application of Ascites-infiltrating Gamma-delta T Cells for Adoptive Immunotherapy. Anticancer Research. 38(7). 4327–4331. 9 indexed citations
5.
Shimizu, Tatsuya, et al.. (2018). Endometrial regeneration using cell sheet transplantation techniques in rats facilitates successful fertilization and pregnancy. Fertility and Sterility. 110(1). 172–181.e4. 23 indexed citations
7.
Hanafusa, Norio, Tomoaki Ishihara, Tetsuya Inoue, et al.. (2017). Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results. PLoS ONE. 12(5). e0177303–e0177303. 35 indexed citations
8.
Takagi, Soichi, Tatsuya Shimizu, Ken Ishitani, et al.. (2014). Reconstruction of functional endometrium-like tissue in vitro and in vivo using cell sheet engineering. Biochemical and Biophysical Research Communications. 446(1). 335–340. 16 indexed citations
9.
Ishitani, Ken, et al.. (2014). Preventive effect of oral mucosal epithelial cell sheets on intrauterine adhesions. Human Reproduction. 30(2). 406–416. 49 indexed citations
10.
Kanno, Hitoshi, Ken Ishitani, Hisaichi Fujii, et al.. (2012). An SNP in CYP39A1 is associated with severe neutropenia induced by docetaxel. Cancer Chemotherapy and Pharmacology. 69(6). 1617–1624. 24 indexed citations
11.
Koga, Yoshikatsu, Masahiro Yasunaga, Masunori Kajikawa, et al.. (2011). Novel virtual cytological analysis for the detection of endometrial cancer cells using autoscan fluoromicroscopy. Cancer Science. 102(5). 1068–1075. 4 indexed citations
12.
Ohta, Hiroaki, et al.. (2010). Familial correlation of bone mineral density, birth data and lifestyle factors among adolescent daughters, mothers and grandmothers. Journal of Bone and Mineral Metabolism. 28(6). 690–695. 19 indexed citations
13.
Shimizu, Mayumi, Yoshiko Onoe, Tatsuhiko Kuroda, et al.. (2009). Variations in Circulating Osteoprotegerin and Soluble RANKL during Diurnal and Menstrual Cycles in Young Women. Hormone Research in Paediatrics. 71(5). 285–289. 15 indexed citations
14.
Hashimoto, Kazunori, Ken Ishitani, & Hiroaki Ohta. (2009). [Usefulness of FRAX and future issues in women's health].. PubMed. 19(12). 1742–8. 3 indexed citations
15.
Shimizu, Shoko, Hiroya Okano, Ken Ishitani, et al.. (2008). Ovarian cystadenofibroma with solid nodular components masqueraded as ovarian cancer. Archives of Gynecology and Obstetrics. 279(5). 709–711. 7 indexed citations
17.
Ishitani, Ken, et al.. (2005). Analysis of fatty acid composition in human bone marrow aspirates. The Keio Journal of Medicine. 54(3). 150–155. 17 indexed citations
18.
Ikeda, Toshiyuki, et al.. (2005). Status of climacteric symptoms among middle‐aged to elderly Japanese women: Comparison of general healthy women with women presenting at a menopausal clinic. Journal of obstetrics and gynaecology research. 31(2). 164–171. 17 indexed citations
19.
Makita, Kazuya, Ken Ishitani, Kiyoshi Takamatsu, et al.. (2004). Relation between climacteric symptoms and ovarian hypofunction in middle-aged and older Japanese women. Menopause The Journal of The North American Menopause Society. 11(6, Part 1 of 2). 631–638. 23 indexed citations
20.
Ishitani, Ken, et al.. (2003). p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor. Biochemical and Biophysical Research Communications. 306(3). 660–665. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026